UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-22909
STERIGENICS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
4020 Clipper Court, Fremont, California 94538, (510) 770-9000
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, par value $0.001 per share
and the associated rights to purchase
Series A Junior Participating Preferred Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) |X| Rule 12h-3(b)(1)(i) |_|
Rule 12g-4(a)(1)(ii) |_| Rule 12h-3(b)(1)(ii) |_|
Rule 12g-4(a)(2)(i) |_| Rule 12h-3(b)(2)(i) |_|
Rule 12g-4(a)(2)(ii) |_| Rule 12h-3(b)(2)(ii) |_|
Rule 15d-6 |_|
Approximate number of holders of record as of the certification or notice
date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934
SteriGenics International, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
Date: July 27, 1999 By: /s/ RAMON P. MARKS
-------------------- -------------------------------------------
Ramon P. Marks, Esq.
Counsel for SteriGenics International, Inc.
